OmniSpirant Therapeutics
PrivateLast Round
Seed
Jan 14, 2025
Total Funding Raised
$13.81M
Momentum Score
50 /100
Company Overview
OmniSpirant Therapeutics is a biotechnology company developing a first-in-class regenerative gene therapy platform, 'OmniSomes', for RNA-based treatments targeting respiratory diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmniSpirant Therapeutics Comps
Public and private peers based on sector, stage, and business model.
OmniSpirant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Grant | Jun 1, 2022 | ||||
| Grant | Feb 1, 2019 |
OmniSpirant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emily's Entourage | Grant |
| Horizon Europe | Grant |
| Cystic Fibrosis Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Grew 30% QoQ from 10 to 13 employees.
- May 1, 2025
Monthly visitors increased 1258% MoM, from 19 to 258.
OmniSpirant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OmniSpirant Therapeutics's valuation, stock price, and market status.
